ADAR1 Capital Management Reports Acquisition of $1.46 Million in Tenax Therapeutics Common Shares

• ADAR1 Capital Management reported purchases of 922,849 Tenax Therapeutics common shares, increasing reported indirect beneficial ownership to 7,447,000 shares.
• Daniel Schneeberger, ADAR1’s manager, also reported indirect beneficial ownership. Both reporting owners are listed as 10% owners.
• Purchases comprised 336,528 shares at $1.5066, 254,342 shares at $1.5952 and 331,979 shares at $1.6588.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000027), on October 21, 2026, and is solely responsible for the information contained therein.